134 related articles for article (PubMed ID: 20439850)
1. Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.
Sánchez-Carteyron A; Alarcia R; Ara JR; Martín J
Neurology; 2010 May; 74(18):1471-3. PubMed ID: 20439850
[No Abstract] [Full Text] [Related]
2. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
Pellkofer HL; Suessmair C; Schulze A; Hohlfeld R; Kuempfel T
Mult Scler; 2009 Aug; 15(8):1006-8. PubMed ID: 19667025
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Berger JR; Neltner J; Smith C; Cambi F
Mult Scler Relat Disord; 2014 Nov; 3(6):728-31. PubMed ID: 25891552
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
Jacob A; Weinshenker BG; Violich I; McLinskey N; Krupp L; Fox RJ; Wingerchuk DM; Boggild M; Constantinescu CS; Miller A; De Angelis T; Matiello M; Cree BA
Arch Neurol; 2008 Nov; 65(11):1443-8. PubMed ID: 18779415
[TBL] [Abstract][Full Text] [Related]
5. Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).
Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A
Neurol Sci; 2007 Aug; 28(4):209-11. PubMed ID: 17690854
[TBL] [Abstract][Full Text] [Related]
6. An open label study of the effects of rituximab in neuromyelitis optica.
Cree BA; Lamb S; Morgan K; Chen A; Waubant E; Genain C
Neurology; 2005 Apr; 64(7):1270-2. PubMed ID: 15824362
[TBL] [Abstract][Full Text] [Related]
7. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
Mangat P; Ravindran J; Cleland L; Limaye V
Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
[TBL] [Abstract][Full Text] [Related]
8. [Neuromyelitis optica with atypical cerebral lesions demonstrated by magnetic resonance imaging in a 9-year old girl].
Trautner S; Pedersen H; Bendtson I
Ugeskr Laeger; 2009 Jan; 171(5):334-6. PubMed ID: 19176174
[TBL] [Abstract][Full Text] [Related]
9. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus.
Birnbaum J; Kerr D
Nat Clin Pract Rheumatol; 2008 Jul; 4(7):381-6. PubMed ID: 18493269
[TBL] [Abstract][Full Text] [Related]
10. Capillary leak syndrome in neuromyelitis optica treated with rituximab.
Fuentes Fernandez I; Hernandez-Clares R; Carreón Guarnizo E; Meca Lallana JE
Mult Scler Relat Disord; 2017 Aug; 16():22-23. PubMed ID: 28755680
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica following CMV primo-infection.
Tran C; Du Pasquier RA; Cavassini M; Guex-Crosier Y; Meuli R; Ciuffreda D; Waeber G
J Intern Med; 2007 May; 261(5):500-3. PubMed ID: 17444889
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of rituximab treatment for neuromyelitis optica.
Fernández-Megía MJ; Casanova-Estruch B; Pérez-Miralles F; Ruiz-Ramos J; Alcalá-Vicente C; Poveda-Andrés JL
Neurologia; 2015 Oct; 30(8):461-4. PubMed ID: 25444411
[TBL] [Abstract][Full Text] [Related]
14. Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
Goncalves MV; Melo LH; Benedet CM; Ribas FD; Cabral NL; Fragoso YD
CNS Neurosci Ther; 2015 Nov; 21(11):914-5. PubMed ID: 26404521
[No Abstract] [Full Text] [Related]
15. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
Weinstock-Guttman B; Miller C; Yeh E; Stosic M; Umhauer M; Batra N; Munschauer F; Zivadinov R; Ramanathan M
Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
[TBL] [Abstract][Full Text] [Related]
16. Primary Sjögrens syndrome presenting as neuromyelitis optica.
Gökçay F; Celebisoy N; Gökçay A; Kabasakal Y; Oder G
Pediatr Neurol; 2007 Jan; 36(1):58-60. PubMed ID: 17162200
[TBL] [Abstract][Full Text] [Related]
17. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
Petereit HF; Rubbert-Roth A
Mult Scler; 2009 Feb; 15(2):189-92. PubMed ID: 18971221
[TBL] [Abstract][Full Text] [Related]
18. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).
Weinstock-Guttman B; Ramanathan M; Lincoff N; Napoli SQ; Sharma J; Feichter J; Bakshi R
Arch Neurol; 2006 Jul; 63(7):957-63. PubMed ID: 16831964
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of pediatric neuromyelitis optica.
Lotze TE; Northrop JL; Hutton GJ; Ross B; Schiffman JS; Hunter JV
Pediatrics; 2008 Nov; 122(5):e1039-47. PubMed ID: 18838462
[TBL] [Abstract][Full Text] [Related]
20. Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Mealy MA; Levy M
J Neuroimmunol; 2015 Oct; 287():29-30. PubMed ID: 26439958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
